Cell Cryopreservation Medium

Cell Cryopreservation Medium Market Outlook

The global Cell Cryopreservation Medium Market was valued at approximately USD 1.8 billion in 2023 and is projected to reach USD 3.2 billion by 2035, growing at a CAGR of 6.4% over the forecast period. This growth is significantly propelled by the increasing demand for cell therapies, advancements in regenerative medicine, and the growing prevalence of chronic diseases requiring stem cell treatment. The expanding applications in biobanking and research, along with the rising investments in pharmaceutical and biotechnology companies focused on cell preservation techniques, are also contributing to the market expansion. Furthermore, the untapped potential in emerging economies is anticipated to provide lucrative opportunities as awareness and technical skills improve in these regions. All these factors together paint a promising picture for the cell cryopreservation medium industry in the coming years.

Growth Factor of the Market

The growth of the Cell Cryopreservation Medium Market is largely driven by the increasing prevalence of diseases that require cell- and tissue-based therapies. With the rise in chronic conditions such as diabetes, cancer, and neurological disorders, there is a growing need for effective preservation methods to ensure the viability of cells for therapeutic applications. Additionally, advancements in cell-based therapies, including cellular immunotherapy and regenerative medicine, are propelling demand for high-quality cryopreservation media that can enhance the survival rates of cells post-thaw. Regulatory support and funding for stem cell research further bolster market growth, as they facilitate the development of innovative preservation techniques and products. Moreover, the growing emphasis on research and development in stem cell biology and regenerative medicine is expected to drive the market forward. Alongside these factors, the increasing focus on biobanks for the storage of biological samples presents additional opportunities for market expansion.

Key Highlights of the Market

• Growing demand for stem cell therapies is a primary driver for market expansion.
• Technological advancements in cryopreservation techniques are enhancing cell viability.
• Biobanks are gaining popularity, leading to increased investments in storage solutions.
• Emerging markets are presenting new opportunities due to increasing healthcare awareness.
• Regulatory initiatives are supporting the development of effective cryopreservation methods.

By Product Type

Serum-based Medium:

Serum-based media have long been a cornerstone in the cell cryopreservation landscape, offering essential nutrients, hormones, and growth factors that support cellular metabolism and viability during the freezing process. They serve as a natural source of various proteins, which play a crucial role in maintaining cellular functions while preventing ice crystal formation during cryopreservation. The inclusion of serum, particularly fetal bovine serum (FBS), enhances the overall effectiveness of the preservation medium, making it a popular choice among researchers and biotechnologists. However, ethical concerns surrounding the use of animal-derived products are prompting a gradual shift towards alternative solutions, thereby influencing the market dynamics.

Serum-free Medium:

Serum-free media are increasingly gaining traction in the cell cryopreservation market due to their ability to eliminate variability associated with serum components and reduce the risk of contamination. These media are specifically formulated with a defined composition of nutrients, growth factors, and other molecular components, which allows for a more controlled environment for cell preservation. The advantages of serum-free media include improved reproducibility in experimental results and reduced batch-to-batch variations. As regulatory scrutiny increases and ethical considerations rise, serum-free options are anticipated to take a more substantial share of the market, appealing to a broader demographic of researchers looking for consistent and reliable preservation methods.

Protein-based Medium:

Protein-based media offer a sophisticated approach to cell cryopreservation by utilizing specific proteins that closely mimic the cellular environment. They contain essential proteins that protect cells during the freezing and thawing processes, which is crucial for maintaining cell integrity and functionality. The increasing focus on personalized medicine and targeted therapies has fueled demand for protein-based cryopreservation solutions, as they are more aligned with the specific requirements of various cell types. The adaptability of protein-based media to different research and clinical applications further enhances their market appeal, making them a valuable segment in the overall landscape.

Chemically Defined Medium:

Chemically defined media are formulated with a precise composition of nutrients, vitamins, and amino acids, ensuring a high level of control over the conditions under which cells are cryopreserved. This type of medium is gaining popularity due to its ability to support the growth and preservation of various cell types without relying on undefined supplements. The predictability of chemically defined media enables researchers to conduct more reliable experiments and develop reproducible results. As researchers increasingly seek standardized methodologies in cellular studies, the demand for chemically defined cryopreservation media is expected to rise, positioning it as a key player in the market.

Specialty Medium:

Specialty media cater to specific cellular requirements and are formulated to address the unique challenges faced during the cryopreservation of particular cell types. These media can include specialized additives that enhance the cryoprotective properties, thereby improving cell survival rates post-thaw. As the demand for specialized applications, such as stem cell research and regenerative medicine, grows, so does the need for tailored cryopreservation solutions. Specialty media provide the necessary support for unique cellular environments, ensuring that the integrity and functionality of cells are preserved during the freezing process. The growing market for regenerative therapies is likely to foster the development and use of various specialty media, thereby enriching this segment within the overall market.

By Application

Stem Cell Preservation:

Stem cell preservation represents one of the most significant applications in the cell cryopreservation medium market. As stem cell therapies continue to gain prominence in regenerative medicine for treating various chronic diseases and conditions, effective preservation methods are essential to ensure the viability and functionality of these precious cells. The demand for reliable cryopreservation solutions in this segment is being driven by advancements in clinical applications, such as hematopoietic stem cell transplants and regenerative treatments. Given the critical role of stem cells in personalized medicine, the focus on innovative storage solutions is expected to increase, further propelling market growth in this area.

Cell Line Preservation:

Cell line preservation is crucial for research and pharmaceutical development, as it involves maintaining the integrity of established cell lines for future use in experiments and drug development. The consistent growth and functionality of these cell lines are imperative for generating reproducible and reliable research results. As researchers and developers emphasize the importance of cell line banks, the demand for effective cryopreservation media tailored for cell lines is growing. This segment is expected to thrive as a result of increasing investments in cellular research and the rising number of biopharmaceutical companies developing novel therapeutics.

Tissue Preservation:

Tissue preservation involves the storage of biological tissues, which can be vital for translational research, organ transplantation, and regenerative medicine. The need for effective cryopreservation techniques for tissues is burgeoning, owing to the rising incidence of organ failures and the demand for transplantable organs. With advancements in cryopreservation technology, tissue preservation is becoming more accessible and reliable, thereby expanding its application in various medical fields. As researchers and healthcare providers focus on improving storage methods for tissues and organ grafts, this segment is poised for substantial growth in the coming years, driven by the need for more effective transplantation strategies.

Organ Preservation:

Organ preservation is a critical application within the cell cryopreservation market, particularly in the context of organ transplantation. The success of organ transplants largely hinges on the ability to preserve organs effectively during transport and storage. Cryopreservation media specifically designed for organs can help mitigate cellular damage and maintain organ viability until transplantation. As the demand for organ transplants continues to rise, driven by an aging population and increasing incidences of organ failure, the need for effective organ preservation solutions will become more pressing. The development of advanced cryopreservation techniques tailored for organ preservation will likely be a significant focus area moving forward.

Other Applications:

In addition to the primary applications listed above, there are various other applications for cell cryopreservation media, including the preservation of gametes, embryos, and various types of primary cells. These applications extend to reproductive medicine, fertility treatments, and research areas focused on developmental biology. The diverse range of applications necessitates the continued development of specialized cryopreservation solutions that cater to the unique requirements of different cell types. As awareness of the importance of cryopreservation grows, the market for these alternative applications is expected to expand significantly, further strengthening the overall cell cryopreservation medium market.

By Distribution Channel

Hospitals & Clinics:

Hospitals and clinics are primary distribution channels for cell cryopreservation media, as they are often at the forefront of providing treatments that require the preservation of biological materials. The increasing number of specialized medical centers offering regenerative therapies and cell-based treatments is driving the demand within this segment. Hospitals are equipped with advanced technologies for cell therapy, and they utilize cryopreservation media for both autologous and allogenic cell storage. As more physicians recognize the potential benefits of cell therapies, hospitals and clinics are likely to expand their capabilities, creating a more substantial market for cryopreservation solutions.

Biobanks:

Biobanks play a crucial role in the cell cryopreservation medium market, serving as dedicated facilities for the storage and preservation of biological samples for research and clinical purposes. These organizations facilitate the long-term storage of cells, tissues, and other biological materials, ensuring that they remain viable for future research or therapeutic use. The increasing focus on personalized medicine and genomic research has led to a surge in biobank establishments, thereby driving the demand for effective cryopreservation media. As biobanks continue to expand their operations, the need for high-quality cryopreservation solutions will become increasingly vital, positioning this channel as a key component of the overall market.

Research Laboratories:

Research laboratories are another essential distribution channel for cell cryopreservation media, as they are heavily involved in cellular biology studies, drug discovery, and various experimental applications. The demand for cryopreservation media in research settings is driven by the need to maintain the viability of cell cultures and facilitate repeatability in experiments. With the rise of various research initiatives focused on regenerative medicine and stem cell research, laboratories require reliable and effective cryopreservation solutions. This segment is expected to grow significantly as investment in research funding increases, further solidifying laboratories as a crucial market driver.

Others:

The "Others" category within the distribution channel segment encompasses various entities, including educational institutions, private research organizations, and specialty biotech firms. These organizations often engage in advanced research and development that necessitates the use of cryopreservation media. The growing interest in stem cell research and regenerative therapies will likely expand the market for these alternative distribution channels. As educational institutions and smaller biotech companies embrace innovative research initiatives, they will increasingly seek effective cryopreservation solutions, thereby contributing to the overall market growth.

By Ingredient Type

DMSO-based:

DMSO (Dimethyl Sulfoxide)-based cryopreservation media are widely used due to their exceptional cryoprotective properties, which allow for the effective preservation of a variety of cell types. DMSO works by preventing ice formation within cells, thereby minimizing cellular damage during the freezing process. Its ability to permeate cell membranes effectively makes it a popular choice in the cryopreservation of stem cells, sperm, and embryos. However, DMSO also has potential cytotoxic effects, which can vary depending on concentration and exposure time. As a result, there is ongoing research aimed at optimizing DMSO-based formulations to enhance cell viability while minimizing toxicity.

FBS-based:

Fetal Bovine Serum (FBS)-based cryopreservation media have long been the standard in many laboratories due to their rich composition of growth factors, hormones, and proteins essential for cell growth and preservation. FBS enhances the survivability of cells during the freezing and thawing processes, making it a go-to option for researchers working with various cell types. Although ethical concerns regarding the use of animal-derived products are prompting a shift towards serum-free alternatives, FBS remains a vital ingredient in many cryopreservation protocols, especially in cell lines where the full benefits of serum supplementation are well-documented.

Glycerol-based:

Glycerol-based media are often utilized for the cryopreservation of mammalian cells due to their exceptional ability to protect against ice crystal formation during the freezing process. Glycerol acts as a cryoprotectant that permeates cell membranes, helping to stabilize cellular structures and maintain viability. These media are particularly advantageous for the preservation of red blood cells, as glycerol can effectively prevent hemolysis during freezing and thawing. The growing demand for blood products and the increasing focus on blood transfusion safety will likely enhance the market for glycerol-based cryopreservation solutions in the coming years.

Cryoprotectant-based:

Cryoprotectant-based media incorporate various synthetic and natural compounds specifically designed to safeguard cells during the freezing process. These cryoprotectants work by preventing ice formation and minimizing osmotic stress, which can lead to cellular injury. The development of novel cryoprotectants that offer improved compatibility with different cell types is critical for advancing the field of cryopreservation. As research progresses towards more innovative solutions, the demand for specialized cryoprotectant-based media is expected to grow, especially in the context of regenerative medicine and stem cell therapies where cell viability is paramount.

Other Ingredients:

The "Other Ingredients" category includes various components that may be utilized in cryopreservation media, such as sugars, amino acids, and antioxidants. These ingredients can play a vital role in enhancing cell viability and functionality during the preservation process. For instance, sugars can help to stabilize biological membranes, while specific amino acids may provide essential building blocks for protein synthesis during recovery post-thaw. Additionally, antioxidants can help mitigate oxidative stress, further enhancing cell survival rates. As researchers continue to explore new formulations and combinations of these ingredients, the market for enhanced cryopreservation media will likely experience significant growth.

By Region

The North American region dominates the Cell Cryopreservation Medium Market, accounting for approximately 45% of global market share in 2023. The substantial market presence in this region can be attributed to the high level of investment in research and development, robust healthcare infrastructure, and a growing number of biopharmaceutical companies engaged in regenerative medicine. Furthermore, the presence of leading market players and extensive academic research institutions contribute to the overall growth of the cryopreservation market in North America. The region is expected to witness a steady CAGR of 6.1% during the forecast period, driven by advances in cell therapies and increasing clinical trials.

Europe follows closely, holding around 30% of the global market share. The growth of the European market is fueled by the increasing focus on regenerative medicine, advancements in cell-based therapies, and a strong emphasis on biobanking. Regulatory support for stem cell research and the establishment of various biobanks across the region are further bolstering market growth. Countries such as Germany, the UK, and France are leading in terms of market share, driven by their well-developed healthcare systems and ongoing research initiatives. Meanwhile, the Asia Pacific region is expected to witness rapid growth, with a CAGR of 7.2%, supported by increasing healthcare expenditure and a rising awareness of stem cell therapies.

Opportunities

As the global focus on personalized medicine and regenerative therapies continues to rise, there are significant opportunities for growth in the Cell Cryopreservation Medium Market. The increasing incidence of chronic diseases such as cancer, diabetes, and cardiovascular conditions has spurred a demand for effective cell therapies that rely on reliable cryopreservation techniques. Moreover, as advancements in biotechnology enable the development of more sophisticated cell cultures and therapy solutions, the need for high-quality cryopreservation media is expected to escalate. Organizations that innovate and develop tailored cryopreservation solutions to cater to specific applications will likely capture a larger share of the market. Additionally, the expansion of biobanks and research laboratories in emerging markets presents a substantial opportunity for industry players to introduce their products and establish a foothold in these rapidly evolving sectors.

Furthermore, the increasing collaborations between academic institutions and biotechnology companies for research and development will contribute to the advancement of cryopreservation techniques. As researchers seek to optimize preservation methods for various cell types, there will be growing demand for specialized media that enhance cell viability and functionality during the freezing and thawing processes. The continuous evolution of regulations surrounding stem cell research and regenerative medicine is also expected to drive market growth, as organizations adapt to meet these standards. Overall, the dynamic landscape of cellular research and biobanking presents numerous opportunities for stakeholders in the cell cryopreservation medium market to innovate and expand their offerings.

Threats

Despite the promising growth prospects in the Cell Cryopreservation Medium Market, there are several threats that could hinder market expansion. One of the primary challenges is the ethical concerns surrounding the use of animal-derived products, particularly in serum-based media. The increasing regulatory scrutiny regarding the use of fetal bovine serum (FBS) and other animal-derived ingredients has led to a push for serum-free alternatives. Companies that are heavily reliant on these traditional formulations may find themselves at a disadvantage in a market that is rapidly shifting towards ethical and sustainable practices. Furthermore, the development of alternative techniques, such as 3D cell culture and organ-on-chip technology, may potentially diminish the relevance of cryopreservation methods, posing a challenge to market participants.

Another significant threat to the market is the intense competition among key players, leading to price wars and the necessity for continuous innovation. Companies must invest heavily in research and development to stay ahead of competitors and meet the evolving needs of researchers and clinicians. The rapid pace of technological advancements necessitates constant adaptation, which can strain resources for smaller players in the market. Additionally, disruptions in the supply chain for raw materials used in cryopreservation media could impact production capabilities, affecting the ability to meet growing demand. Therefore, market participants must navigate these challenges strategically to maintain their competitive edge and ensure sustained growth.

Competitor Outlook

• Thermo Fisher Scientific
• Merck KGaA
• Lonza Group AG
• STEMCELL Technologies Inc.
• Corning Incorporated
• BioLife Solutions, Inc.
• Fujifilm Irvine Scientific
• ReproCELL Inc.
• Sigma-Aldrich Corporation
• VWR International, LLC
• Cellutron Life Technologies
• Horizon Discovery Group plc
• Biovision Inc.
• Kita Pharmaceuticals
• InVivo Therapeutics Holdings Corp.

The competitive landscape of the Cell Cryopreservation Medium Market is characterized by a mix of established players and emerging companies, each vying for market share through innovation and strategic partnerships. The leading companies are heavily investing in research and development to create advanced cryopreservation media that cater to the specific needs of various cell types. Collaborations with academic institutions and research organizations are becoming increasingly prevalent, as these partnerships enable companies to access cutting-edge research and technologies that can enhance their product offerings. Additionally, geographic expansion into emerging markets presents a significant opportunity for these firms to tap into new customer bases and bolster sales.

Thermo Fisher Scientific stands out as a leader in the cell cryopreservation medium market, offering a diverse range of products tailored to different applications. The company is known for its commitment to quality and innovation, providing reliable cryopreservation solutions that meet the rigorous demands of researchers and clinicians. With a strong global presence and a comprehensive portfolio of cell culture media, Thermo Fisher is well-positioned to capture growth opportunities in this dynamic market. Similarly, Merck KGaA has emerged as a key player, leveraging its extensive product range and robust distribution networks to cater to the evolving needs of the cell cryopreservation market.

Lonza Group AG is also a prominent player in the industry, renowned for its expertise in cell culture and cryopreservation. The company is focused on developing high-quality, serum-free media to address the growing demand for ethical and sustainable cryopreservation solutions. Lonza's commitment to innovation is evident through its continuous investment in research and development, enabling the company to remain at the forefront of technological advancements in the market. Additionally, BioLife Solutions, Inc. has gained traction in the cell cryopreservation space, offering specialized cryopreservation media designed to enhance cell viability. The company's emphasis on developing high-performance products tailored for the regenerative medicine sector positions it well to capitalize on emerging opportunities in the market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Merck KGaA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Biovision Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Lonza Group AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 ReproCELL Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Corning Incorporated
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Kita Pharmaceuticals
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 VWR International, LLC
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 BioLife Solutions, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Thermo Fisher Scientific
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Sigma-Aldrich Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Fujifilm Irvine Scientific
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 STEMCELL Technologies Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Cellutron Life Technologies
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Horizon Discovery Group plc
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 InVivo Therapeutics Holdings Corp.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Cell Cryopreservation Medium Market, By Application
    • 6.1.1 Stem Cell Preservation
    • 6.1.2 Cell Line Preservation
    • 6.1.3 Tissue Preservation
    • 6.1.4 Organ Preservation
    • 6.1.5 Other Applications
  • 6.2 Cell Cryopreservation Medium Market, By Product Type
    • 6.2.1 Serum-based Medium
    • 6.2.2 Serum-free Medium
    • 6.2.3 Protein-based Medium
    • 6.2.4 Chemically Defined Medium
    • 6.2.5 Specialty Medium
  • 6.3 Cell Cryopreservation Medium Market, By Distribution Channel
    • 6.3.1 Hospitals & Clinics
    • 6.3.2 Biobanks
    • 6.3.3 Research Laboratories
    • 6.3.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Cell Cryopreservation Medium Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Cell Cryopreservation Medium market is categorized based on

By Product Type

• Serum-based Medium
• Serum-free Medium
• Protein-based Medium
• Chemically Defined Medium
• Specialty Medium

By Application

• Stem Cell Preservation
• Cell Line Preservation
• Tissue Preservation
• Organ Preservation
• Other Applications

By Distribution Channel

• Hospitals & Clinics
• Biobanks
• Research Laboratories
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Merck KGaA
• Lonza Group AG
• STEMCELL Technologies Inc.
• Corning Incorporated
• BioLife Solutions, Inc.
• Fujifilm Irvine Scientific
• ReproCELL Inc.
• Sigma-Aldrich Corporation
• VWR International, LLC
• Cellutron Life Technologies
• Horizon Discovery Group plc
• Biovision Inc.
• Kita Pharmaceuticals
• InVivo Therapeutics Holdings Corp.